<DOC>
	<DOCNO>NCT00282659</DOCNO>
	<brief_summary>The purpose study determine magnesium improve blood pressure , cholesterol , blood sugar control patient implantable cardioverter defibrillator ( ICDs ) .</brief_summary>
	<brief_title>The Use Magnesium Improve Blood Pressure , Cholesterol , Glucose Control</brief_title>
	<detailed_description>Magnesium second abundant intracellular cation play vital role many physiologic process . It determine patient cardiovascular disease intracellular magnesium ( Mgi ) deficiency . Among ICD registry Europe United States 64 % 77 % patient also carry diagnosis CAD , respectively . Patients CAD risk factor lead development propagation atherosclerosis . Paramount among risk factor hypertension , dyslipidemia , diabetes . Comparison : Magnesium compare placebo patient ICDs evaluate effect cholesterol , blood pressure , blood glucose .</detailed_description>
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<mesh_term>Dyslipidemias</mesh_term>
	<criteria>Newly implant ICD recent ICD shock ( within 6 month ) Inability swallow A noncardiac disease survival prognosis le 12 month Hypermagnesemia Creatinine clearance le 30mL/min Lactic acidosis systemic acidosis syndrome Previous intolerance magnesium Llactate</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2007</verification_date>
	<keyword>Hemodynamics</keyword>
	<keyword>Hypertension</keyword>
	<keyword>Dyslipidemia</keyword>
	<keyword>Diabetes</keyword>
	<keyword>Implantable Cardioverter Defibrillator</keyword>
	<keyword>Blood Pressure</keyword>
</DOC>